Actively Recruiting

Phase 2
Age: 2Weeks - 17Years
All Genders
ID07123961

Pediatric Acute Respiratory Distress Syndrome (ARDS) Management (PARMA) Trial

Led by Children's Hospital of Philadelphia · Updated on 2026-03-16

160

Participants Needed

1

Research Sites

25 weeks

Total Duration

On this page

Sponsors

C

Children's Hospital of Philadelphia

Lead Sponsor

U

University of Pennsylvania

Collaborating Sponsor

AI-Summary

What this Trial Is About

Acute respiratory distress syndrome (ARDS) in children is a serious lung condition that can be life-threatening. Current ventilator settings are often based on adult treatments, but children's bodies respond differently, so it is important to find the best ventilator approach for pediatric patients. This trial compares two ventilator strategies to see which one might provide better support for children with ARDS and will help guide future larger studies. Children already on a breathing machine will be randomly assigned to receive one of two pressure settings: a high driving pressure set to 25 cmH2O or a low driving pressure set to 15 cmH2O using a specific ventilator model (Evita V500). All other clinical care, including sedation and fluid management, will follow standard practices. Lung imaging using Electrical Impedance Tomography (EIT) will be done up to four times during the study to observe lung aeration. Participants will be monitored for up to 672 hours to assess sustained improvement in oxygen levels. Additional assessments include lung imaging at several time points after randomization and clinical outcomes such as mortality, ICU and hospital discharge, ventilator-free days, and safety events like pneumothorax or pneumonia. The study follow-up lasts up to 90 days to track these outcomes and safety endpoints.

CONDITIONS

Brief Title

Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial

Who Can Participate

Age: 2Weeks - 17Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age over 2 weeks (more than 38 weeks corrected gestational age) and under 18 years (not yet 18th birthday)
  • Acute respiratory failure starting within 7 days requiring invasive mechanical ventilation
  • Ventilated with endotracheal tube or tracheostomy for 7 days or less from risk factor onset
  • Hypoxemia with specific oxygenation measurements sustained at consent and randomization
  • Bilateral opacities on chest X-ray confirmed by radiologist or clinical team
Not Eligible

You will not qualify if you...

  • Hypoxemia mainly caused by heart failure or fluid overload
  • Unrepaired or non-palliated cyanotic congenital heart disease
  • Ventilated via tracheostomy before current acute illness
  • Obstructive airway disease as main cause of respiratory failure
  • Expected to survive less than 72 hours due to severe moribund state
  • Any limitations on care at screening time
  • Already escalated to high frequency oscillatory ventilation or extracorporeal support at screening
  • Previous participation in this study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 28 days or until resolution of respiratory failure

Participants receive mechanical ventilation with either high or low driving pressure settings while standard clinical care continues. They will have an Electrical Impedance Tomography (EIT) device strap placed on their chest up to four times during the study to image lung aeration.

Multiple visits during mechanical ventilation

Follow-up

Duration - Up to 90 days

Participants are monitored for clinical outcomes including survival, ventilator-free days, and adverse events up to hospital discharge or 90 days after enrollment.

Periodic follow-up visits until hospital discharge or 90 days

Trial Site Locations

Total: 1 location

1

The Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

Loading map...

Research Team

H

Helena Wiatrowski, B.A.

S

Stephen Famularo III, B.A.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Prospective, Single-center, Randomized, Double-blind Contr...

Acute Respiratory Distress Syndrome (ARDS)

Actively Recruiting

1 location

A Trial of the Difference in Staff Time Involved in Repositi...

Acute Respiratory Distress Syndrome (ARDS)

Actively Recruiting

1 location

The Contribution of the Combination of Transthoracic and Tra...

Acute Respiratory Distress Syndrome (ARDS)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here